{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:05:41Z","timestamp":1791821141438,"version":"4.3.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00203-025-04663-y","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T07:29:10Z","timestamp":1768202950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Berberine as a therapeutic alkaloid against ESKAPE and multiple drug-resistant bacteria: a comprehensive review"],"prefix":"10.1007","volume":"208","author":[{"given":"Sushmita","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harjot Singh","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithul","family":"Rajeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moupriya","family":"Nag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibyajit","family":"Lahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasmita","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debapriya","family":"Maitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"4663_CR1","doi-asserted-by":"crossref","unstructured":"Exploring the Role of Berberine as a Molecular Disruptor in Antimicrobial Strategies [Internet]. [cited 2025 Aug 27]. Available from: https:\/\/www.mdpi.com\/1424-8247\/18\/7\/947","DOI":"10.3390\/ph18070947"},{"key":"4663_CR2","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2475067","volume":"2016","author":"S Santajit","year":"2016","unstructured":"Santajit S, Indrawattana N (2016) Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed Res Int 2016:2475067","journal-title":"Biomed Res Int"},{"key":"4663_CR3","doi-asserted-by":"crossref","first-page":"7313","DOI":"10.2147\/IDR.S431256","volume":"16","author":"H Zhou","year":"2023","unstructured":"Zhou H, Wang W, Cai L, Yang T (2023) Potentiation and mechanism of Berberine as an antibiotic adjuvant against multidrug-resistant bacteria. IDR 16:7313\u20137326","journal-title":"IDR"},{"issue":"7","key":"4663_CR4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3390\/ph18070947","volume":"18","author":"A Duda-Madej","year":"2025","unstructured":"Duda-Madej A, Viscardi S, Bazan H, Sobieraj J (2025) Exploring the role of Berberine as a molecular disruptor in antimicrobial strategies. Pharmaceuticals (Basel) 18(7):947","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"4663_CR5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.22271\/phyto.2023.v12.i3c.14682","volume":"12","author":"D Goti","year":"2023","unstructured":"Goti D, Dasgupta DS (2023) A comprehensive review of conventional and non-conventional solvent extraction techniques. J Pharmacogn Phytochem 12(3):202\u2013211","journal-title":"J Pharmacogn Phytochem"},{"issue":"15","key":"4663_CR6","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.3390\/plants11152011","volume":"11","author":"E Nortjie","year":"2022","unstructured":"Nortjie E, Basitere M, Moyo D, Nyamukamba P (2022) Extraction methods, quantitative and qualitative phytochemical screening of medicinal plants for antimicrobial textiles: a review. Plants 11(15):2011","journal-title":"Plants"},{"issue":"30","key":"4663_CR7","doi-asserted-by":"crossref","first-page":"24596","DOI":"10.1039\/D5RA02170G","volume":"15","author":"S Huang","year":"2025","unstructured":"Huang S, Huang G (2025) A comprehensive review of recent advances in the extraction and therapeutic potential of berberine. RSC Adv 15(30):24596\u2013611","journal-title":"RSC Adv"},{"key":"4663_CR8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fphar.2018.00557","volume":"9","author":"MA Neag","year":"2018","unstructured":"Neag MA, Mocan A, Echeverr\u00eda J, Pop RM, Bocsan CI, Cri\u015fan G et al (2018) Berberine: botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders. Front Pharmacol 9:557","journal-title":"Front Pharmacol"},{"key":"4663_CR9","doi-asserted-by":"crossref","first-page":"762654","DOI":"10.3389\/fphar.2021.762654","volume":"12","author":"X Ai","year":"2021","unstructured":"Ai X, Yu P, Peng L, Luo L, Liu J, Li S et al (2021) Berberine: a review of its pharmacokinetics properties and therapeutic potentials in diverse vascular diseases. Front Pharmacol 12:762654","journal-title":"Front Pharmacol"},{"key":"4663_CR10","doi-asserted-by":"crossref","first-page":"1368950","DOI":"10.3389\/fphar.2024.1368950","volume":"15","author":"A Sun","year":"2024","unstructured":"Sun A, Yang H, Li T, Luo J, Zhou L, Chen R et al (2024) Molecular mechanisms, targets and clinical potential of Berberine in regulating metabolism: a review focussing on databases and molecular docking studies. Front Pharmacol 15:1368950","journal-title":"Front Pharmacol"},{"key":"4663_CR11","doi-asserted-by":"crossref","first-page":"157030","DOI":"10.1016\/j.phymed.2025.157030","volume":"146","author":"W Zhou","year":"2025","unstructured":"Zhou W, Asif A, Situ C, Wang J, Hao H (2025) Multiple target and regulatory pathways of berberine. Phytomedicine 146:157030","journal-title":"Phytomedicine"},{"key":"4663_CR12","doi-asserted-by":"crossref","first-page":"110984","DOI":"10.1016\/j.biopha.2020.110984","volume":"133","author":"X Xu","year":"2021","unstructured":"Xu X, Yi H, Wu J, Kuang T, Zhang J, Li Q et al (2021) Therapeutic effect of Berberine on metabolic diseases: both Pharmacological data and clinical evidence. Biomed Pharmacother 133:110984","journal-title":"Biomed Pharmacother"},{"key":"4663_CR13","doi-asserted-by":"publisher","unstructured":"Sun P, Wang Z, Ma Y, Liu Y, Xue Y, Li Y et al Advance in identified targets of berberine. Front Pharmacol [Internet]. 2025 Jan 29 [cited 2025 Aug 27];16. Available from: https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/https:\/\/doi.org\/10.3389\/fphar.2025.1500511\/full","DOI":"10.3389\/fphar.2025.1500511\/full"},{"issue":"3","key":"4663_CR14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ijbiomac.2012.01.029","volume":"50","author":"D Naveen Chandra","year":"2012","unstructured":"Naveen Chandra D, Abhilash J, Prasanth GK, Sabu A, Sadasivan C, Haridas M (2012) Inverted binding due to a minor structural change in berberine enhances its phospholipase A2 inhibitory effect. Int J Biol Macromol 50(3):578\u2013585","journal-title":"Int J Biol Macromol"},{"key":"4663_CR15","doi-asserted-by":"crossref","unstructured":"Chu M, Ding R, Chu Z, yun, Zhang M bo, Liu X, Xie S et al (2014) Role of berberine in anti-bacterial as a high-affinity LPS antagonist binding to TLR4\/MD-2 receptor. BMC Complement Altern Med. 14(1):89","DOI":"10.1186\/1472-6882-14-89"},{"key":"4663_CR16","doi-asserted-by":"publisher","unstructured":"Chu M, Chen X, Wang J, Guo L, Wang Q, Gao Z et al (2018) Polypharmacology of Berberine Based on Multi-Target Binding Motifs. Front Pharmacol [Internet]. Jul 24 [cited 2025 Aug 27];9. Available from: https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/https:\/\/doi.org\/10.3389\/fphar.2018.00801\/full","DOI":"10.3389\/fphar.2018.00801\/full"},{"key":"4663_CR17","doi-asserted-by":"crossref","first-page":"141639","DOI":"10.1016\/j.foodchem.2024.141639","volume":"464","author":"SJ Wu","year":"2025","unstructured":"Wu SJ, Feng R, Meng R, Ji QY, Tao H, Xu BC et al (2025) Exploring the binding mechanism and functional properties of lactoferrin-berberine complex: based on multispectral analysis, molecular docking, and dynamics simulations. Food Chem 464:141639","journal-title":"Food Chem"},{"key":"4663_CR18","first-page":"315","volume":"22","author":"P Nadalin","year":"2023","unstructured":"Nadalin P, Kim YG, Park SU (2023) Recent studies on berberine and its biological and pharmacological activities. EXCLI J 22:315\u2013328","journal-title":"EXCLI J"},{"issue":"1","key":"4663_CR19","volume":"2011","author":"Y Chen","year":"2011","unstructured":"Chen Y, Wang Y, Zhang J, Sun C, Lopez A (2011) Berberine improves glucose homeostasis in streptozotocin-induced diabetic rats in association with multiple factors of insulin resistance. International Scholarly Research Notices 2011(1):519371","journal-title":"International Scholarly Research Notices"},{"key":"4663_CR20","unstructured":"Berberine in Cardiovascular and Metabolic Diseases From Mechanisms to Therapeutics - PMC [Internet]. [cited 2025 Aug 24]. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6485276\/"},{"key":"4663_CR21","doi-asserted-by":"publisher","unstructured":"Wu S, Yang K, Hong Y, Gong Y, Ni J, Yang N et al A New Perspective on the Antimicrobial Mechanism of Berberine Hydrochloride Against Staphylococcus aureus Revealed by Untargeted Metabolomic Studies. Front Microbiol [Internet]. 2022 Jul 13 [cited 2025 Aug 27];13. Available from: https:\/\/www.frontiersin.org\/journals\/microbiology\/articles\/https:\/\/doi.org\/10.3389\/fmicb.2022.917414\/full","DOI":"10.3389\/fmicb.2022.917414\/full"},{"issue":"6","key":"4663_CR22","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s10787-022-01080-1","volume":"30","author":"AO Babalghith","year":"2022","unstructured":"Babalghith AO, Al-kuraishy HM, Al-Gareeb AI, De Waard M, Al-Hamash SM, Jean-Marc S et al (2022) The role of berberine in Covid-19: potential adjunct therapy. Inflammopharmacology 30(6):2003\u20132016","journal-title":"Inflammopharmacology"},{"issue":"10","key":"4663_CR23","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3390\/antiox12101883","volume":"12","author":"E Tian","year":"2023","unstructured":"Tian E, Sharma G, Dai C (2023) Neuroprotective properties of berberine: molecular mechanisms and clinical implications. Antioxid (Basel) 12(10):1883","journal-title":"Antioxid (Basel)"},{"issue":"23","key":"4663_CR24","doi-asserted-by":"crossref","first-page":"8367","DOI":"10.3390\/molecules27238367","volume":"27","author":"A Naeem","year":"2022","unstructured":"Naeem A, Hu P, Yang M, Zhang J, Liu Y, Zhu W et al (2022) Natural products as anticancer agents: current status and future perspectives. Molecules 27(23):8367","journal-title":"Molecules"},{"key":"4663_CR25","unstructured":"CDC (2019) Antibiotic Resistance Threats Report [Internet]. Antimicrobial Resistance. 2025 [cited 2025 Aug 27]. Available from: https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/index.html"},{"issue":"2","key":"4663_CR26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/14787210.2021.1951705","volume":"20","author":"G Sulis","year":"2022","unstructured":"Sulis G, Sayood S, Gandra S (2022) Antimicrobial resistance in low- and middle-income countries: current status and future directions. Expert Rev Anti Infect Ther 20(2):147\u2013160","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4663_CR27","unstructured":"Antimicrobial resistance risk associated with antibiotic overuse and initiatives to reduce the problem - Carl Llor, Lars Bjerrum, 2014 [Internet]. [cited 2025 Aug 27]. Available from: https:\/\/journals.sagepub.com\/doi\/full\/10.1177\/2042098614554919"},{"issue":"1","key":"4663_CR28","first-page":"2","volume":"9","author":"SS Aghayan","year":"2017","unstructured":"Aghayan SS, Mogadam HK, Fazli M, Darban-Sarokhalil D, Khoramrooz SS, Jabalameli F et al (2017) The effects of Berberine and palmatine on efflux pumps Inhibition with different gene patterns in Pseudomonas aeruginosa isolated from burn infections. Avicenna J Med Biotechnol 9(1):2\u20137","journal-title":"Avicenna J Med Biotechnol"},{"issue":"1","key":"4663_CR29","doi-asserted-by":"crossref","first-page":"e01239","DOI":"10.1128\/msystems.01239-22","volume":"8","author":"T Dehau","year":"2023","unstructured":"Dehau T, Cherlet M, Croubels S, van Immerseel F, Goossens E (2023) A high dose of dietary Berberine improves gut wall Morphology, despite an expansion of Enterobacteriaceae and a reduction in beneficial microbiota in broiler chickens. mSystems 8(1):e01239\u2013e01222","journal-title":"mSystems"},{"key":"4663_CR30","unstructured":"Mechanistic Understanding of Antibiotic Resistance in ESKAPE Pathogens | Request PDF. In: ResearchGate [Internet]. [cited 2025 Aug 27]. Available from: https:\/\/www.researchgate.net\/publication\/379415016_Mechanistic_Understanding_of_Antibiotic_Resistance_in_ESKAPE_Pathogens"},{"key":"4663_CR31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3389\/fmicb.2020.00621","volume":"11","author":"X Zhang","year":"2020","unstructured":"Zhang X, Sun X, Wu J, Wu Y, Wang Y, Hu X et al (2020) Berberine damages the cell surface of Methicillin-Resistant Staphylococcus aureus. Front Microbiol 11:621","journal-title":"Front Microbiol"},{"key":"4663_CR32","doi-asserted-by":"crossref","first-page":"940282","DOI":"10.3389\/fphar.2022.940282","volume":"13","author":"L Fu","year":"2022","unstructured":"Fu L, Mou J, Deng Y, Ren X (2022) Structural modifications of Berberine and their binding effects towards polymorphic deoxyribonucleic acid structures: a review. Front Pharmacol 13:940282","journal-title":"Front Pharmacol"},{"issue":"3","key":"4663_CR33","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijpddr.2014.07.006","volume":"4","author":"R Bala\u00f1a-Fouce","year":"2014","unstructured":"Bala\u00f1a-Fouce R, \u00c1lvarez-Velilla R, Fern\u00e1ndez-Prada C, Garc\u00eda-Estrada C, Reguera RM (2014) Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery. Int J Parasitol Drugs Drug Resist 4(3):326\u2013337","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"2","key":"4663_CR34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1211\/jpp.58.2.0015","volume":"58","author":"S Letasiov\u00e1","year":"2006","unstructured":"Letasiov\u00e1 S, Jantov\u00e1 S, Miko M, Ov\u00e1dekov\u00e1 R, Horv\u00e1thov\u00e1 M (2006) Effect of Berberine on proliferation, biosynthesis of macromolecules, cell cycle and induction of intercalation with DNA, DsDNA damage and apoptosis in Ehrlich Ascites carcinoma cells. J Pharm Pharmacol 58(2):263\u2013270","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"4663_CR35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/antibiotics12010015","volume":"12","author":"JA Pavlova","year":"2022","unstructured":"Pavlova JA, Tereshchenkov AG, Nazarov PA, Lukianov DA, Skvortsov DA, Polshakov VI et al (2022) Conjugates of Chloramphenicol amine and Berberine as antimicrobial agents. Antibiot (Basel) 12(1):15","journal-title":"Antibiot (Basel)"},{"issue":"9","key":"4663_CR36","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.str.2024.06.013","volume":"32","author":"Z Batool","year":"2024","unstructured":"Batool Z, Pavlova JA, Paranjpe MN, Tereshchenkov AG, Lukianov DA, Osterman IA et al (2024) Berberine analog of chloramphenicol exhibits a distinct mode of action and unveils ribosome plasticity. Structure 32(9):1429-1442e6","journal-title":"Structure"},{"issue":"6","key":"4663_CR37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065674","volume":"24","author":"A Di Somma","year":"2023","unstructured":"Di Somma A, Can\u00e8 C, Rotondo NP, Cavalluzzi MM, Lentini G, Duilio A (2023) A comparative study of the inhibitory action of berberine derivatives on the recombinant protein FtsZ of E. coli. Int J Mol Sci 24(6):5674","journal-title":"Int J Mol Sci"},{"key":"4663_CR38","doi-asserted-by":"publisher","unstructured":"Liu JY, Dai Y, He YX, Lin L Effect of berberine on cognitive function and \u03b2-amyloid precursor protein in Alzheimer\u2019s disease models: a systematic review and meta-analysis. Front Pharmacol [Internet]. 2024 Jan 16 [cited 2025 Aug 27];14. Available from: https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/https:\/\/doi.org\/10.3389\/fphar.2023.1301102\/full","DOI":"10.3389\/fphar.2023.1301102\/full"},{"key":"4663_CR39","doi-asserted-by":"publisher","unstructured":"Role of Berberine as a Potential Efflux Pump Inhibitor against MdfA from Escherichia coli: In Vitro and In Silico Studies | Microbiology Spectrum [Internet]. [cited 2025 Aug 27]. Available from: https:\/\/journals.asm.org\/doi\/full\/https:\/\/doi.org\/10.1128\/spectrum.03324-22","DOI":"10.1128\/spectrum.03324-22"},{"key":"4663_CR40","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1055\/s-0030-1250606","volume":"77","author":"KA Ettefagh","year":"2010","unstructured":"Ettefagh KA, Burns JT, Junio HA, Kaatz GW, Cech NB (2010) Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine via efflux pump inhibition. Planta Med 77:835\u2013840","journal-title":"Planta Med"},{"issue":"3","key":"4663_CR41","first-page":"289","volume":"45","author":"SS Hendi","year":"2021","unstructured":"Hendi SS, Haghighi H, Shahriari S (2021) Evaluation of the ability of barberry liquid extract to prevent the formation of microbial biofilm by Enterococcus faecalis: an in vitro study. J Mashhad Dent School 45(3):289\u2013298","journal-title":"J Mashhad Dent School"},{"key":"4663_CR42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.micres.2016.03.003","volume":"186\u2013187","author":"L Chen","year":"2016","unstructured":"Chen L, Bu Q, Xu H, Liu Y, She P, Tan R et al (2016) The effect of Berberine hydrochloride on Enterococcus faecalis biofilm formation and dispersion in vitro. Microbiol Res 186\u2013187:44\u201351","journal-title":"Microbiol Res"},{"key":"4663_CR43","doi-asserted-by":"crossref","first-page":"26003","DOI":"10.1038\/s41598-025-11226-0","volume":"15","author":"F Zhou","year":"2025","unstructured":"Zhou F, Gu X, Lin M, Dai Y, Wang W, Xiong Z et al (2025) Mechanistic studies on the effect of berberine on methicillin-resistant Staphylococcus aureus drug resistance through modulation of wall teichoteic acid. Sci Rep 15:26003","journal-title":"Sci Rep"},{"key":"4663_CR44","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12866-024-03692-9","volume":"24","author":"F Zhou","year":"2024","unstructured":"Zhou F, Gu X, Wang W, Lin M, Wang L (2024) Advancements in MRSA treatment: the role of berberine in enhancing antibiotic therapy. BMC Microbiol 24:540","journal-title":"BMC Microbiol"},{"issue":"9","key":"4663_CR45","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.4014\/jmb.2105.05015","volume":"31","author":"ET Jeong","year":"2021","unstructured":"Jeong ET, Park SK, Jo DM, Khan F, Choi TH, Yoon TM et al (2021) Synergistic antibacterial activity of an active compound derived from sedum takesimense against Methicillin-Resistant Staphylococcus aureus and its clinical isolates. J Microbiol Biotechnol 31(9):1288\u20131294","journal-title":"J Microbiol Biotechnol"},{"issue":"1","key":"4663_CR46","doi-asserted-by":"crossref","first-page":"24748","DOI":"10.1038\/srep24748","volume":"6","author":"M Chu","year":"2016","unstructured":"Chu M, Zhang M, Liu Y, Kang J, Chu Z, Yin K et al (2016) Role of Berberine in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections. Sci Rep. 6(1):24748","journal-title":"Sci Rep."},{"key":"4663_CR47","doi-asserted-by":"crossref","first-page":"100247","DOI":"10.1016\/j.microb.2025.100247","volume":"6","author":"H Kaushik","year":"2025","unstructured":"Kaushik H, Sharma R, Kumar A (2025) Natural products against resistant bacterial infections: A systematic literature review. Microbe 6:100247","journal-title":"Microbe"},{"issue":"2","key":"4663_CR48","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/antibiotics12020234","volume":"12","author":"T Karampatakis","year":"2023","unstructured":"Karampatakis T, Tsergouli K, Behzadi P (2023) Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiot (Basel) 12(2):234","journal-title":"Antibiot (Basel)"},{"key":"4663_CR49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.micres.2016.12.003","volume":"196","author":"R Barbieri","year":"2017","unstructured":"Barbieri R, Coppo E, Marchese A, Daglia M, Sobarzo-S\u00e1nchez E, Nabavi SF et al (2017) Phytochemicals for human disease: an update on plant-derived compounds antibacterial activity. Microbiol Res 196:44\u201368","journal-title":"Microbiol Res"},{"key":"4663_CR50","doi-asserted-by":"crossref","first-page":"660431","DOI":"10.3389\/fcimb.2021.660431","volume":"11","author":"X Li","year":"2021","unstructured":"Li X, Song Y, Wang L, Kang G, Wang P, Yin H et al (2021) A potential combination therapy of berberine hydrochloride with antibiotics against multidrug-resistant acinetobacter baumannii. Front Cell Infect Microbiol 11:660431","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4663_CR51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.30699\/ijmm.14.1.44","volume":"14","author":"H Mahmoudi","year":"2020","unstructured":"Mahmoudi H, Zare Fahim N, Alikhani MY, Shokoohizadeh L (2020) Investigation of antimicrobial effect of berberine on ciprofloxacin and imipenem resistance acinetobacter baumannii isolated from Hamadan hospitals. Iran J Med Microbiol 14(1):44\u201354","journal-title":"Iran J Med Microbiol"},{"key":"4663_CR52","doi-asserted-by":"publisher","unstructured":"Morita Y, Nakashima K, ichi, Nishino K, Kotani K, Tomida J, Inoue M et al (2016) Berberine Is a Novel Type Efflux Inhibitor Which Attenuates the MexXY-Mediated Aminoglycoside Resistance in Pseudomonas aeruginosa. Front Microbiol [Internet]. Aug 5 [cited 2025 Aug 27];7. Available from: https:\/\/www.frontiersin.org\/journals\/microbiology\/articles\/https:\/\/doi.org\/10.3389\/fmicb.2016.01223\/full","DOI":"10.3389\/fmicb.2016.01223\/full"},{"issue":"1","key":"4663_CR53","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12866-024-03692-9","volume":"24","author":"F Zhou","year":"2024","unstructured":"Zhou F, Gu X, Wang W, Lin M, Wang L (2024) Advancements in MRSA treatment: the role of berberine in enhancing antibiotic therapy. BMC Microbiol 24(1):540","journal-title":"BMC Microbiol"},{"issue":"23","key":"4663_CR54","volume":"28","author":"J Li","year":"2023","unstructured":"Li J, Zhang Q, Chen Y, Lu C, Tong Y (2023) Pharmacokinetics, tissue distribution and excretion of demethyleneberberine, a metabolite of berberine, in rats and mice. Molecules 28(23):7725","journal-title":"Molecules"},{"key":"4663_CR55","unstructured":"(PDF) Acute toxicity of berberine and its correlation with the blood concentration in mice. ResearchGate [Internet]. (2025) Aug 26 [cited 2025 Aug 27]; Available from: https:\/\/www.researchgate.net\/publication\/41412717_Acute_toxicity_of_berberine_and_its_correlation_with_the_blood_concentration_in_mice"},{"issue":"05","key":"4663_CR56","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1142\/S0192415X14500669","volume":"42","author":"C Chen","year":"2014","unstructured":"Chen C, Yu Z, Li Y, Fichna J, Storr M (2014) Effects of berberine in the Gastrointestinal Tract \u2014 a review of actions and therapeutic implications. Am J Chin Med 42(05):1053\u20131070","journal-title":"Am J Chin Med"},{"issue":"1","key":"4663_CR57","volume":"34","author":"R Jadimurthy","year":"2022","unstructured":"Jadimurthy R, Mayegowda SB, Nayak SC, Mohan CD, Rangappa KS (2022) Escaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds. Biotechnol Rep 34(1):e00728","journal-title":"Biotechnol Rep"},{"key":"4663_CR58","first-page":"168","volume":"89","author":"A Herman","year":"2022","unstructured":"Herman A, Herman AP (2022) Herbal products and their active constituents used alone and in combination with antibiotics against Multidrug-Resistant bacteria. Planta Med 89:168\u2013182","journal-title":"Planta Med"},{"issue":"1","key":"4663_CR59","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12866-020-02003-2","volume":"20","author":"X Li","year":"2020","unstructured":"Li X, Wang P, Hu X, Zhang Y, Lu X, Li C et al (2020) The combined antibacterial effects of sodium new houttuyfonate and berberine chloride against growing and persistent methicillin-resistant and vancomycin-intermediate Staphylococcus aureus. BMC Microbiol 20(1):317","journal-title":"BMC Microbiol"},{"issue":"9","key":"4663_CR60","doi-asserted-by":"crossref","first-page":"10322","DOI":"10.3390\/molecules170910322","volume":"17","author":"GY Zuo","year":"2012","unstructured":"Zuo GY, Li Y, Han J, Wang GC, Zhang YL, Bian ZQ (2012) Antibacterial and synergy of berberines with antibacterial agents against clinical multi-drug resistant isolates of Methicillin-Resistant Staphylococcus aureus (MRSA). Molecules 17(9):10322\u201310330","journal-title":"Molecules"},{"key":"#cr-split#-4663_CR61.1","doi-asserted-by":"crossref","unstructured":"Jain AK, Singh D, Dubey K, Maurya R, Mittal S, Pandey AK (2018) Models and Methods for In Vitro Toxicity. In: In Vitro Toxicology [Internet]. Elsevier","DOI":"10.1016\/B978-0-12-804667-8.00003-1"},{"key":"#cr-split#-4663_CR61.2","unstructured":"[cited 2023 Aug 11]. pp. 45-65. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128046678000031"},{"key":"4663_CR62","doi-asserted-by":"publisher","unstructured":"Effects of Berberine in the Gastrointestinal Tract \u2014 A Review of Actions and Therapeutic Implications | The American Journal of Chinese Medicine [Internet]. [cited 2025 Aug 24]. Available from: https:\/\/www.worldscientific.com\/doi\/abs\/https:\/\/doi.org\/10.1142\/S0192415X14500669","DOI":"10.1142\/S0192415X14500669"},{"issue":"6","key":"4663_CR63","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/jac\/dkaf084","volume":"80","author":"S Mancini","year":"2025","unstructured":"Mancini S, Greiner M, Egli A, Nolte O (2025) In vitro susceptibility testing of vancomycin-resistant Enterococcus faecium to fosfomycin. J Antimicrob Chemother 80(6):1742\u20131744","journal-title":"J Antimicrob Chemother"},{"key":"4663_CR64","doi-asserted-by":"publisher","unstructured":"Endothelial BACE Bridging the Gap Between Hypertension and Alzheimer\u2019s Disease | Circulation Research [Internet]. [cited 2025 Aug 27]. Available from: https:\/\/www.ahajournals.org\/doi\/full\/https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.321078","DOI":"10.1161\/CIRCRESAHA.122.321078"},{"key":"4663_CR65","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Solache M, Rice LB (2019) The enterococcus: a model of adaptability to its environment. Clin Microbiol Rev. https:\/\/doi.org\/10.1128\/cmr.0005818","DOI":"10.1128\/cmr.0005818"},{"issue":"6","key":"4663_CR66","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/med.20202","volume":"31","author":"K Bhadra","year":"2011","unstructured":"Bhadra K, Kumar GS (2011) Therapeutic potential of nucleic acid-binding isoquinoline alkaloids: binding aspects and implications for drug design. Med Res Rev 31(6):821\u2013862","journal-title":"Med Res Rev"},{"issue":"6","key":"4663_CR67","volume":"86","author":"Rrong Wang","year":"2025","unstructured":"Wang Rrong, Wu H, Feng Mling, Zhong Jli, Li Rxi, Zhou Bxuan (2025) Berberine as a multi-targeted therapeutic agent in melanoma: mechanisms, efficacy, and combination therapies. Drug Dev Res 86(6):e70144","journal-title":"Drug Dev Res"},{"key":"4663_CR68","doi-asserted-by":"crossref","first-page":"824420","DOI":"10.3389\/fphar.2022.824420","volume":"13","author":"WQ Zhu","year":"2022","unstructured":"Zhu WQ, Wu HY, Sun ZH, Guo Y, Ge TT, Li BJ et al (2022) Current evidence and future directions of berberine intervention in depression. Front Pharmacol 13:824420","journal-title":"Front Pharmacol"},{"issue":"6","key":"4663_CR69","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10096-007-0456-4","volume":"27","author":"ME Falagas","year":"2008","unstructured":"Falagas ME, Kanellopoulou MD, Karageorgopoulos DE, Dimopoulos G, Rafailidis PI, Skarmoutsou ND et al (2008) Antimicrobial susceptibility of multidrug-resistant gram negative bacteria to fosfomycin. Eur J Clin Microbiol Infect Dis 27(6):439\u2013443","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04663-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-025-04663-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04663-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:05:04Z","timestamp":1771272304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-025-04663-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4663"],"URL":"https:\/\/doi.org\/10.1007\/s00203-025-04663-y","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"115"}}